Abstrakt
As cases of gallbladder-related adverse events have been reported in patients treated with glucagon-like peptide (GLP)-1 receptor agonists and GLP-2 receptor agonists, studies have investigated the effects of these hormones on the enterohepatic circulation of bile acids and gallbladder motility. Results suggest, that bile acids and GLP-2 counteract postprandial cholecystokinin-mediated gallbladder contraction, while GLP-1 may delay gallbladder refilling. This provides important information on the effect and safety of drugs based on GLP-1 and GLP-2, respectively.
Bidragets oversatte titel | Effects of glucagon-like peptides on gallbladder motility |
---|---|
Originalsprog | Dansk |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 180 |
Udgave nummer | 50 |
ISSN | 0041-5782 |
Status | Udgivet - 10 dec. 2018 |
Emneord
- Bile Acids and Salts
- Cholecystokinin
- Gallbladder/physiology
- Glucagon-Like Peptide 1/physiology
- Humans